Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erin E Wilhelm

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
JAMA Internal Medicine|December 6, 2017
Drug Trials Snapshots and Sexless Drug LabelsG Elliott Cook, Erin E Wilhelm
Therapeutic Innovation & Regulatory Science|February 3, 2020
Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III TrialsDaphne Guinn, Erin E Wilhelm, Ira Shoulson
JAMA|February 22, 2014
Approaches and costs for sharing clinical research dataErin E Wilhelm, Emily Oster, Ira Shoulson
JAMA Neurology|July 25, 2017
I-SPY 2 Breast Cancer Trial as a Model for Innovation in Alzheimer Disease TherapiesMindi F Messmer, Erin E Wilhelm, Ira Shoulson
Clinical and Translational Science|June 18, 2015
Advancing a Vision for Regulatory Science TrainingJoan E Adamo, Erin E Wilhelm, Scott J Steele
BMJ Evidence-Based Medicine|November 28, 2018
Assessing function of electronic health records for real-world data generationDaphne Guinn, Erin E Wilhelm, Grazyna Lieberman, et al.
Communication & Medicine|November 25, 2015
Data sharing for public health research: A qualitative study of industry and academiaPamela A Saunders, Erin E Wilhelm, Sinae Lee, et al.
Journal of Diabetes and Its Complications|September 24, 2017
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety dataEvgenia Gourgari, Erin E Wilhelm, Hamid Hassanzadeh, et al.
The Patient|August 3, 2017
Erratum to: Inaugural Conference on Incorporating Patient-Reported Outcomes and Patient Preference Information into Clinical Research, Clinical Care, and Risk-Benefit Assessments for Neurodegenerative DiseasesJennifer L Purks, Erin E Wilhelm, Ira Shoulson, et al.
The Patient|July 9, 2017
Inaugural Conference on Incorporating Patient-Reported Outcomes and Patient Preference Information into Clinical Research, Clinical Care, and Risk-Benefit Assessments for Neurodegenerative DiseasesJennifer L Purks, Erin E Wilhelm, Ira Shoulson, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
JAMA Internal Medicine|December 6, 2017
Drug Trials Snapshots and Sexless Drug LabelsG Elliott Cook, Erin E Wilhelm
Therapeutic Innovation & Regulatory Science|February 3, 2020
Reasons for Premature Conclusion of Late Phase Clinical Trials: An Analysis of ClinicalTrials.gov Registered Phase III TrialsDaphne Guinn, Erin E Wilhelm, Ira Shoulson
JAMA|February 22, 2014
Approaches and costs for sharing clinical research dataErin E Wilhelm, Emily Oster, Ira Shoulson
JAMA Neurology|July 25, 2017
I-SPY 2 Breast Cancer Trial as a Model for Innovation in Alzheimer Disease TherapiesMindi F Messmer, Erin E Wilhelm, Ira Shoulson
Clinical and Translational Science|June 18, 2015
Advancing a Vision for Regulatory Science TrainingJoan E Adamo, Erin E Wilhelm, Scott J Steele
BMJ Evidence-Based Medicine|November 28, 2018
Assessing function of electronic health records for real-world data generationDaphne Guinn, Erin E Wilhelm, Grazyna Lieberman, et al.
Communication & Medicine|November 25, 2015
Data sharing for public health research: A qualitative study of industry and academiaPamela A Saunders, Erin E Wilhelm, Sinae Lee, et al.
Journal of Diabetes and Its Complications|September 24, 2017
A comprehensive review of the FDA-approved labels of diabetes drugs: Indications, safety, and emerging cardiovascular safety dataEvgenia Gourgari, Erin E Wilhelm, Hamid Hassanzadeh, et al.
The Patient|August 3, 2017
Erratum to: Inaugural Conference on Incorporating Patient-Reported Outcomes and Patient Preference Information into Clinical Research, Clinical Care, and Risk-Benefit Assessments for Neurodegenerative DiseasesJennifer L Purks, Erin E Wilhelm, Ira Shoulson, et al.
The Patient|July 9, 2017
Inaugural Conference on Incorporating Patient-Reported Outcomes and Patient Preference Information into Clinical Research, Clinical Care, and Risk-Benefit Assessments for Neurodegenerative DiseasesJennifer L Purks, Erin E Wilhelm, Ira Shoulson, et al.
Pageof 1